Why are antiepileptic drugs used for nonepileptic conditions?

Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity

(2012) Claudiu T Supuran   EXPERT OPINION ON EMERGING DRUGS

Antiepileptic drugs in the treatment of psychiatric disorders

(2011) Kenneth R. Kaufman   EPILEPSY & BEHAVIOR

Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation

(2011) V. Bril et al.   NEUROLOGY

Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial

(2010) Y Bersudsky et al.   BIPOLAR DISORDERS

Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X)

(2010) Meir Bialer et al.   EPILEPSY RESEARCH

Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders

(2010) Massimo Mantegazza et al.   LANCET NEUROLOGY

The anticonvulsants market

(2010) Charlotte Mackey   NATURE REVIEWS DRUG DISCOVERY

Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acid

(2010) Dan Kaufmann et al.   NEUROPHARMACOLOGY

Anticonvulsants for Neuropathic Pain

(2009) Felicity Goodyear-Smith et al.   CLINICAL JOURNAL OF PAIN

Antiepileptic Drugs in Non-Epilepsy Disorders

(2009) Cecilie Johannessen Landmark   CNS DRUGS

Key factors in the discovery and development of new antiepileptic drugs

(2009) Meir Bialer et al.   NATURE REVIEWS DRUG DISCOVERY

How does gabapentin relieve neuropathic pain?

(2009) Marshall Devor   PAIN

Gabapentin selectively reduces persistent sodium current in injured type-A dorsal root ganglion neurons

(2009) Rui-Hua Yang et al.   PAIN

Mechanisms of analgesia by gabapentin and pregabalin – Calcium channel α2-δ [Cavα2-δ] ligands

(2009) Charles P. Taylor   PAIN

Pharmacokinetics of Licarbazepine in Healthy Volunteers: Single and Multiple Oral Doses and Effect of Food

(2008) Claire Souppart et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The Mood-Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase-3

(2003) Guang Chen et al.   JOURNAL OF NEUROCHEMISTRY